Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients

NCT05748925 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

SLE
Lupus Nephritis
SGLT2 Inhibitors

Interventions

DRUG: dapagliflozin
DRUG: placebo

Sponsor

Mansoura University